ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,715
0,21%
Bitcoin
57 330,23
-1,56%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Immunic Inc (IMUX)

  7. Immunic Inc (IMUX) Actualités

IMUX Immunic Inc

1,2709
0,0109 (0,87%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Immunic Inc IMUX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0109 0,87% 1,2709 00:33:43
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,29 1,26 1,34 1,30 1,26
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202412:30PRNUSImmunic, Inc. to Announce Financial Results for the First..
30/4/202412:30PRNUSImmunic Announces Publication of Extended Data From Phase 2..
04/4/202412:30PRNUSImmunic to Host MS R&D Day and Participate in Investor..
20/3/202411:30PRNUSImmunic Receives Notice of Allowance for..
08/3/202422:05EDGAR2Form 8-K - Current report
07/3/202412:30PRNUSImmunic to Participate in Investor and Scientific..
07/3/202403:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202403:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202403:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202412:30PRNUSImmunic Presents Data From Phase 2 CALLIPER and CALVID-1..
22/2/202412:38EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202412:35EDGAR2Form 8-K - Current report
22/2/202412:30PRNUSImmunic, Inc. Reports Year End 2023 Financial Results and..
15/2/202412:30PRNUSImmunic, Inc. to Announce Financial Results for the Year..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:36EDGAR2Form S-3 - Registration statement under Securities Act of..
05/2/202414:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/2/202412:30PRNUSImmunic to Participate in Investor and Scientific..
24/1/202423:05EDGAR2Form PRE 14A - Other preliminary proxy statements
19/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form D - Notice of Exempt Offering of Securities
16/1/202422:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/1/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202412:41EDGAR2Form 8-K - Current report
05/1/202412:35PRNUSImmunic Highlights 2023 Accomplishments and Upcoming..
05/1/202412:30PRNUSImmunic, Inc. Announces Private Placement of up to $240..
21/12/202314:30EDGAR2Form 8-K - Current report
22/11/202322:20EDGAR2Form S-3 - Registration statement under Securities Act of..
21/11/202312:30PRNUSImmunic Receives Notice of Allowance for United States..
14/11/202312:38EDGAR2Form 8-K - Current report
14/11/202312:30PRNUSImmunic, Inc. Reports Third Quarter 2023 Financial Results..
07/11/202312:30PRNUSImmunic to Announce Financial Results for the Third Quarter..
02/11/202311:30PRNUSImmunic Receives Notice of Allowance for United States..
26/10/202312:30PRNUSImmunic to Participate in Scientific and Industry..
18/10/202322:05EDGAR2Form 8-K - Current report
16/10/202312:30PRNUSImmunic Presents Data From Phase 2 CALDOSE-1 Trial of..
15/10/202312:30PRNUSImmunic Presents Data From Phase 1b Clinical Trial of..
11/10/202312:30PRNUSImmunic Presents Data From Phase 2 EMPhASIS Trial of..
10/10/202314:48EDGAR2Form 8-K - Current report
09/10/202322:01PRNUSImmunic Reports Positive Interim Data from Phase 2 CALLIPER..
04/10/202312:30PRNUSImmunic to Participate in Scientific Conferences in October
06/9/202312:30PRNUSImmunic to Participate in Industry and Investor Conferences..

Dernières Valeurs Consultées

NASDAQ
IMUX
Immunic
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés